Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Lundbeck acquires exclusive rights to KW-6356 from Kyowa Hakko Kirin

Oct. 6, 2010

Cortex Pharma regains rights to Ampakine agents for depression and schizophrenia

Oct. 5, 2010

Argenta and Janssen enter into cancer drug discovery agreement

Oct. 5, 2010

Eisai and Anaeropharma partner to discover Bifidobacterium-delivered anticancer agents

Oct. 5, 2010

Global marketing rights to Caelyx to transition from Merck & Co. to Janssen

Oct. 5, 2010

Dyax and CMIC partner in development and marketing of DX-88 for HAE in Japan

Oct. 4, 2010

Aveo Pharmaceuticals regains worldwide rights to AV-299

Oct. 4, 2010

Pieris, sanofi-aventis and Sanofi Pasteur to develop anticalin therapeutics

Oct. 1, 2010

Astellas and UMN Pharma enter definitive agreement for flu vaccines

Oct. 1, 2010

Dana-Farber Cancer Institute and sanofi-aventis collaborate on oncology targets

Sep. 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...